HomeIMM • LON
add
ImmuPharma PLC
Previous close
GBX 2.04
Day range
GBX 2.01 - GBX 2.11
Year range
GBX 0.82 - GBX 3.80
Market cap
8.60M GBP
Avg Volume
2.30M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
(GBP) | Jun 2023info | Y/Y change |
---|---|---|
Revenue | 34.98K | — |
Operating expense | 684.19K | -18.04% |
Net income | -423.68K | 49.07% |
Net profit margin | -1.21K | — |
Earnings per share | — | — |
EBITDA | -619.81K | 21.69% |
Effective tax rate | 25.48% | — |
Balance Sheet
Total assets
Total liabilities
(GBP) | Jun 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 210.58K | 23.20% |
Total assets | 3.29M | 14.38% |
Total liabilities | 1.55M | 80.67% |
Total equity | 1.74M | — |
Shares outstanding | 333.40M | — |
Price to book | 2.04 | — |
Return on assets | -49.35% | — |
Return on capital | -93.42% | — |
Cash Flow
Net change in cash
(GBP) | Jun 2023info | Y/Y change |
---|---|---|
Net income | -423.68K | 49.07% |
Cash from operations | -326.46K | 59.80% |
Cash from investing | 732.00 | 2,261.29% |
Cash from financing | 92.42K | 29.44% |
Net change in cash | -228.62K | 69.07% |
Free cash flow | -312.99K | 19.58% |
About
Founded
1999
Website
Employees
13